ProShares UltraPro Short NASDAQ Biotechnology
ZBIO • XNAS
ProShares UltraPro Short NASDAQ Biotechnology is a pharmaceutical preparations company trading on XNAS, led by CEO Leon Oliver Moulder Jr., with a market cap of $1.0B.
CEOLeon Oliver Moulder Jr.
Next Earnings
No upcoming earnings scheduled for ProShares UltraPro Short NASDAQ Biotechnology
No earnings announcement scheduled
Earnings History
Past 5 earnings reports for ProShares UltraPro Short NASDAQ Biotechnology
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$4.54 | — | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$1.22Est: -$0.98 | -24.5% | -Est: $2.8M | -100.0% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$1.25Est: -$1.04 | -20.2% | -Est: $2.8M | -100.0% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.80Est: -$1.05 | +23.8% | $10.0MEst: $1.7M | +498.8% | 10-Q |
| Nov 12, 2024 | Q3 2024 | -$5.02Est: -$9.33 | +46.2% | - | — | 10-Q |